Use of shotgun metagenome sequencing to detect fecal colonization with multidrug-resistant bacteria in children

Journal of Clinical Microbiology

Volumn 54, Issue 7, 2016, Pages 1804-1813

  Andersen, Heidi ^a   Connolly, Natalia ^b   Bangar, Hansraj ^a   Staat, Mary ^a   Mortensen, Joel ^b   Deburger, Barbara ^b   Haslam, David B ^a  

^a Departments of Pediatric Infectious Diseases   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ANAEROBIC BACTERIUM; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIUM; BACTERIUM CULTURE; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; ENTEROCOCCACEAE; FECES ANALYSIS; GENE SEQUENCE; GENETIC PROCEDURES; HIGH RISK PATIENT; HUMAN; INFANT; INFECTION RISK; INTESTINE FLORA; METAGENOME; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL DIVERSITY; MULTIDRUG RESISTANT BACTERIA; MULTIDRUG RESISTANT ENTEROBACTERIACEAE; NONHUMAN; OUTPATIENT; POPULATION ABUNDANCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SHOTGUN METAGENOME SEQUENCING; VANCOMYCIN RESISTANT ENTEROCOCCUS FAECIUM; VANCOMYCIN RESISTANT STAPHYLOCOCCUS AUREUS; ADULT; BACTERIAL INFECTIONS; ENTEROBACTERIACEAE; EVALUATION STUDY; FECES; FEMALE; GENETICS; ISOLATION AND PURIFICATION; MALE; METAGENOMICS; MICROBIOLOGY; MULTIDRUG RESISTANCE; PILOT STUDY; PRESCHOOL CHILD; PROCEDURES; VANCOMYCIN RESISTANT ENTEROCOCCUS; YOUNG ADULT;

ADOLESCENT; ADULT; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTERIACEAE; FECES; FEMALE; HUMANS; INFANT; MALE; METAGENOMICS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PILOT PROJECTS; VANCOMYCIN-RESISTANT ENTEROCOCCI; YOUNG ADULT;

EID: 84976351883     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02638-15     Document Type: Article

References (39)

1. Di Pentima MC, Chan S, Briody C, Power M, Hossain J. 2014. Driving forces of vancomycin-resistant E. faecium and E. faecalis blood-stream infections in children. Antimicrob Resist Infect Control 3:29. http://dx.doi. org/10. 1186/2047-2994-3-29.
2. McNeil JC. 2014. Staphylococcus aureus-antimicrobial resistance and the immunocompromised child. Infect Drug Resist 7:117-127.
3. Sick AC, Tschudin-Sutter S, Turnbull AE, Weissman SJ, Tamma PD. 2014. Empiric combination therapy for Gram-negative bacteremia. Pediatrics 133:e1148-e1155. http://dx. doi. org/10. 1542/peds. 2013-3363.
4. Modi SR, Lee HH, Spina CS, Collins JJ. 2013. Antibiotic treatment expands the resistance reservoir and ecological network of the phage metagenome. Nature 499:219-222. http://dx. doi. org/10. 1038/nature12212.
5. Donskey CJ, Chowdhry TK, Hecker MT, Hoyen CK, Hanrahan JA, Hujer AM, Hutton-Thomas RA, Whalen CC, Bonomo RA, Rice LB. 2000. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med 343:1925-1932. http://dx. doi. org/10. 1056/NEJM200012283432604.
6. Pultz NJ, Stiefel U, Subramanyan S, Helfand MS, Donskey CJ. 2005. Mechanisms by which anaerobic microbiota inhibit the establishment in mice of intestinal colonization by vancomycin-resistant Enterococcus. J Infect Dis 191:949-956. http://dx. doi. org/10. 1086/428090.
7. Perez-Cobas AE, Artacho A, Knecht H, Ferrus ML, Friedrichs A, Ott SJ, Moya A, Latorre A, Gosalbes MJ. 2013. Differential effects of antibiotic therapy on the structure and function of human gut microbiota. PLoS One 8:e80201. http://dx. doi. org/10. 1371/journal. pone. 0080201.
8. Carlet J. 2012. The gut is the epicentre of antibiotic resistance. Antimicrob Resist Infect Control 1:39. http://dx. doi. org/10. 1186/2047-2994-1-39.
9. Penders J, Stobberingh EE, Savelkoul PH, Wolffs PF. 2013. The human microbiome as a reservoir of antimicrobial resistance. Front Microbiol 4:87.
10. Kamboj M, Chung D, Seo SK, Pamer EG, Sepkowitz KA, Jakubowski AA, Papanicolaou G. 2010. The changing epidemiology of vancomycinresistant Enterococcus (VRE) bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients. Biol Blood Marrow Transplant 16: 1576-1581. http://dx. doi. org/10. 1016/j. bbmt. 2010. 05. 008.
11. Ubeda C, Taur Y, Jenq RR, Equinda MJ, Son T, Samstein M, Viale A, Socci ND, van den Brink MR, Kamboj M, Pamer EG. 2010. Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J Clin Invest 120:4332-4341. http://dx. doi. org/10. 1172/JCI43918.
12. Blot S, Depuydt P, Vogelaers D, Decruyenaere J, De Waele J, Hoste E, Peleman R, Claeys G, Verschraegen G, Colardyn F, Vandewoude K. 2005. Colonization status and appropriate antibiotic therapy for nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in an intensive care unit. Infect Control Hosp Epidemiol 26:575-579. http://dx. doi. org/10. 1086/502575.
13. Taur Y, Xavier JB, Lipuma L, Ubeda C, Goldberg J, Gobourne A, Lee YJ, Dubin KA, Socci ND, Viale A, Perales MA, Jenq RR, van den Brink MR, Pamer EG. 2012. Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 55:905-914. http://dx. doi. org/10. 1093/cid/cis580.
14. Kochar S, Sheard T, Sharma R, Hui A, Tolentino E, Allen G, Landman D, Bratu S, Augenbraun M, Quale J. 2009. Success of an infection control program to reduce the spread of carbapenem-resistant Klebsiella pneumoniae. Infect Control Hosp Epidemiol 30:447-452. http://dx. doi. org/10.1086/596734.
15. Centers for Disease Control and Prevention. 2013. Antibiotic resistance threats in the United States, 2013. Centers for Disease Control and Prevention, Atlanta, GA. http://www. cdc. gov/drugresistance/threat-report-2 013/pdf/ar-threats-2013-508. pdf.
16. The White House. 2015. National action plan for combating antibioticresistant bacteria, 2015. The White House, Washington, DC. https://www.whitehouse. gov/sites/default/files/docs/national-action-plan-for-combating-antibotic-resistant-bacteria. pdf.
17. Reddy P, Malczynski M, Obias A, Reiner S, Jin N, Huang J, Noskin GA, Zembower T. 2007. Screening for extended-spectrum beta-lactamaseproducing Enterobacteriaceae among high-risk patients and rates of subsequent bacteremia. Clin Infect Dis 45:846-852. http://dx. doi. org/10.1086/521260.
18. Nesher L, Rolston KV, Shah DP, Tarrand JT, Mulanovich V, Ariza-Heredia EJ, Chemaly RF. 2015. Fecal colonization and infection with Pseudomonas aeruginosa in recipients of allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis 17:33-38. http://dx. doi. org/10.1111/tid. 12323.
19. Soroksky A, Nagornov S, Klinowski E, Leonov Y, Ilgiyaev E, Yossepowitch O, Goltsman G. 2014. Active surveillance cultures in critically ill patients: pathogens, patterns, and correlation with eventual bloodstream infections. Isr Med Assoc J 16:418-422.
20. Wingard JR, Dick J, Charache P, Saral R. 1986. Antibiotic-resistant bacteria in surveillance stool cultures of patients with prolonged neutropenia. Antimicrob Agents Chemother 30:435-439. http://dx. doi. org/10.1128/AAC. 30. 3. 435.
21. Taur Y, Jenq RR, Perales MA, Littmann ER, Morjaria S, Ling L, No D, Gobourne A, Viale A, Dahi PB, Ponce DM, Barker JN, Giralt S, van den Brink M, Pamer EG. 2014. The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. Blood 124:1174-1182. http://dx. doi. org/10. 1182/blood-2014-02-554725.
22. Zapala MA, Schork NJ. 2012. Statistical properties of multivariate distance matrix regression for high-dimensional data analysis. Front Genet 3:190.
23. Kelly BJ, Gross R, Bittinger K, Sherrill-Mix S, Lewis JD, Collman RG, Bushman FD, Li H. 2015. Power and sample-size estimation for microbiome studies using pairwise distances and PERMANOVA. Bioinformatics 31:2461-2468. http://dx. doi. org/10. 1093/bioinformatics/btv183.
24. La Rosa PS, Brooks JP, Deych E, Boone EL, Edwards DJ, Wang Q, Sodergren E, Weinstock G, Shannon WD. 2012. Hypothesis testing and power calculations for taxonomic-based human microbiome data. PLoS One 7:e52078. http://dx. doi. org/10. 1371/journal. pone. 0052078.
25. Currier RL, Payne DC, Staat MA, Selvarangan R, Shirley SH, Halasa N, Boom JA, Englund JA, Szilagyi PG, Harrison CJ, Klein EJ, Weinberg GA, Wikswo ME, Parashar U, Vinje J, Morrow AL. 2015. Innate susceptibility to norovirus infections influenced by FUT2 genotype in a United States pediatric population. Clin Infect Dis 60:1631-1638. http://dx. doi. org/10. 1093/cid/civ165.
26. Aagaard K, Petrosino J, Keitel W, Watson M, Katancik J, Garcia N, Patel S, Cutting M, Madden T, Hamilton H, Harris E, Gevers D, Simone G, McInnes P, Versalovic J. 2013. The Human Microbiome Project strategy for comprehensive sampling of the human microbiome and why it matters. FASEB J 27:1012-1022. http://dx. doi. org/10. 1096/fj.12-220806.
27. Lewis JD, Chen EZ, Baldassano RN, Otley AR, Griffiths AM, Lee D, Bittinger K, Bailey A, Friedman ES, Hoffmann C, Albenberg L, Sinha R, Compher C, Gilroy E, Nessel L, Grant A, Chehoud C, Li H, Wu GD, Bushman FD. 2015. Inflammation, antibiotics, and diet as environmental stressors of the gut microbiome in pediatric Crohn's disease. Cell Host Microbe 18:489-500. http://dx. doi. org/10. 1016/j. chom. 2015. 09. 008.
28. Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA, Bewtra M, Knights D, Walters WA, Knight R, Sinha R, Gilroy E, Gupta K, Baldassano R, Nessel L, Li H, Bushman FD, Lewis JD. 2011. Linking long-term dietary patterns with gut microbial enterotypes. Science 334: 105-108. http://dx. doi. org/10. 1126/science. 1208344.
29. Kim SH, Wei CI. 2007. Expression of AmpC beta-lactamase in Enterobacter cloacae isolated from retail ground beef, cattle farm and processing facilities. J Appl Microbiol 103:400-408. http://dx. doi. org/10. 1111/j. 1365-2672. 2006. 03255. x.
30. Dray S, Dufour AB. 2007. The ade4 package: implementing the duality diagram for ecologists. J Stat Softw 22:1-20.
31. Warnes G, Bolker B, Bonebakker L, Gentleman R, Liaw WHA, Lumley T, Maechler M, Magnusson A. 2009. gplots: Various R programming tools for plotting data. Version 2. 6. 0. The R Foundation, Vienna, Austria.
32. Svetnik V, Liaw A, Tong C, Culberson JC, Sheridan RP, Feuston BP. 2003. Random forest: a classification and regression tool for compound classification and QSAR modeling. J Chem Inf Comput Sci 43:1947-1958. http://dx. doi. org/10. 1021/ci034160g.
33. Diaz-Uriarte R. 2007. GeneSrF and varSelRF: a web-based tool and R package for gene selection and classification using random forest. BMC Bioinformatics 3:328.
34. Bush K, Jacoby GA. 2010. Updated functional classification of betalactamases. Antimicrob Agents Chemother 54:969-976. http://dx. doi. org/10. 1128/AAC. 01009-09.
35. Lahey Clinic. Beta-lactamase classification and amino acid sequences for TEM, SHV, and OXA extended-spectrum and inhibitor resistant enzymes. Lahey Clinic, Burlington, MA. http://www. lahey. org/Studies/.
36. Bartoloni A, Pallecchi L, Benedetti M, Fernandez C, Vallejos Y, Guzman E, Villagran AL, Mantella A, Lucchetti C, Bartalesi F, Strohmeyer M, Bechini A, Gamboa H, Rodriguez H, Falkenberg T, Kronvall G, Gotuzzo E, Paradisi F, Rossolini GM. 2006. Multidrug-resistant commensal Escherichia coli in children, Peru and Bolivia. Emerg Infect Dis 12:907-913. http://dx. doi. org/10. 3201/eid1206. 051258.
37. Fernandez-Reyes M, Vicente D, Gomariz M, Esnal O, Landa J, Onate E, Perez-Trallero E. 2014. High rate of fecal carriage of extended-spectrumbeta-lactamase-producing Escherichia coli in healthy children in Gipuzkoa, northern Spain. Antimicrob Agents Chemother 58:1822-1824. http://dx. doi. org/10. 1128/AAC. 01503-13.
38. Arrieta MC, Stiemsma LT, Amenyogbe N, Brown EM, Finlay B. 2014. The intestinal microbiome in early life: health and disease. Front Immunol 5:427.
39. Ledeboer NA, Tibbetts RJ, Dunne WM. 2007. A new chromogenic agar medium, chromID VRE, to screen for vancomycin-resistant Enterococcus faecium and Enterococcus faecalis. Diagn Microbiol Infect Dis 59:477-479. http://dx. doi. org/10. 1016/j. diagmicrobio. 2007. 06. 018.